Activation of CD8+ T cells and their cytotoxicity against hepatocytes were reported in immune-related liver diseases, such as MASH, AIH, and PSC, primarily in mouse models. The gene discussed is CD8A; the disease is metabolic dysfunction-associated steatohepatitis.